UNDERSTANDING THE ROLE OF SERUM URIC ACID AS A PROGNOSTIC MARKER IN ACUTE CORONARY SYNDROME: A HOSPITAL BASED STUDY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 11
Abstract
BACKGROUND Coronary artery disease remains the dominating cause of death in the world. Despite understanding and controlling the known risk factors for coronary artery disease, it remains the worldwide epidemic. This raises the possibility of the presence of unknown or underestimated risk factors. The role of uric acid as a prognostic factor in patients with acute coronary syndrome is controversial. The aim of the present study is to estimate serum uric acid levels in acute coronary syndrome and its correlation with Killip’s classification of heart failure and in hospital mortality. MATERIALS AND METHODS A total of 100 patients with acute coronary syndrome meeting the inclusion and exclusion criteria, with an equal number of age and sex matched controls were selected for study during the period 1st July 2016 - 30th June 2017. Serum uric acid level was estimated on day 0 and 7 of acute coronary syndrome. RESULTS A statistically significant higher level of serum uric acid concentration in patients of acute coronary syndrome (5.80 ± 1.53) was observed on the day of admission as compared to controls (3.8 ± 0.85). There was no statistically significant difference observed in relation with diabetes and hypertensive status and gender. Higher serum uric acid (>7 mg/dl) level along with higher Killip’s class (III, IV) was associated with higher mortality and major adverse cardiac events. CONCLUSION It is concluded from the present study that serum uric acid levels were higher in patients of ACS as compared to healthy controls. Patients with elevated serum uric acid levels belonged to higher Killip’s classification and had higher mortality. It can be inferred from this study that serum uric acid can be regarded as an inexpensive independent risk factor and prognostic marker for assessing short term mortality in patients with ACS.
Authors and Affiliations
Chandra Prakash Thakur, Kallol Bhattacharjee, Dwijen Das
Keywords
Related Articles
- EP ID EP538005
- DOI 10.18410/jebmh/2018/203
- Views 45
- Downloads 0
OVARIAN DERMOID WITH A MESENTERIC CYST- AN UNUSUAL CO-OCCURRENCE
PRESENTATION OF CASE A 30 year old female patient presented with chronic dullaching abdominal pain since the past 3 years. There was no specific localization of pain. There was no fever or any significant medical history...
ATORVASTATIN IN ACUTE STROKE: A STEPPING STONE TO THE SERENDIPITY
BACKGROUND Stroke is a vascular dismay that has led to several deaths and deformities. Despite this unwarranted picture it is largely preventable and treatable. The statins have been the flagship molecules for the purpos...
THERMAL BURNS IN ADULTS- A RETROSPECTIVE DESCRIPTIVE STUDY
BACKGROUND Burn injuries are of global concern. In India, over 10,00,000 people sustain burns every year. Most of them succumb to death, and the rest suffer with varying degrees of morbidity. A better understanding of th...
MITOCHONDRIAL DNA- REVOLUTIONARY EVOLUTION
BACKGROUND Mitochondrion, the sausage-shaped organelle residing in the cytoplasm of all eukaryotic cells, apart from being the power house, represents endosymbiotic evolution of a free living organism to intracellular st...
A CASE OF HASHIMOTO’S THYROIDITIS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA
Hashimoto’s thyroiditis is a part of the spectrum of autoimmune thyroid disease and it is found to be associated with other autoimmune diseases like Addison’s disease, vitiligo, type1 diabetes mellitus, alopecia areata,...